• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

The design of a sequential clinical trial for the comparison of two lung cancer treatments.

作者信息

Jones D R, Newman C E, Whitehead J

出版信息

Stat Med. 1982 Jan-Mar;1(1):73-82. doi: 10.1002/sim.4780010110.

DOI:10.1002/sim.4780010110
PMID:7187084
Abstract

The steps in designing a controlled trial to evaluate a new treatment for inoperable carcinoma of the bronchus are described. The principal outcome measure is survival time from treatment allocation, and the duration of the trial is determined by application of the sequential logrank test. The detailed determination of the stopping rule and the arrangements for analyses are described.

摘要

相似文献

1
The design of a sequential clinical trial for the comparison of two lung cancer treatments.
Stat Med. 1982 Jan-Mar;1(1):73-82. doi: 10.1002/sim.4780010110.
2
The analysis of a sequential clinical trial for the comparison of two lung cancer treatments.
Stat Med. 1983 Apr-Jun;2(2):183-90. doi: 10.1002/sim.4780020212.
3
Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.在一项随机双盲试验中,与单纯放疗相比,放疗联合丙亚胺用于无法手术的肺癌患者时生存率降低。
Br J Cancer. 1985 May;51(5):731-2. doi: 10.1038/bjc.1985.109.
4
Results of a E.O.R.T.C. Randomized trial of cyclophosphamide and radiotherapy in inoperable lung cancer: prognostic factors and treatment results.欧洲癌症研究与治疗组织(E.O.R.T.C.)关于环磷酰胺与放疗用于不可切除肺癌的随机试验结果:预后因素及治疗结果
Eur J Cancer (1965). 1978 Sep;14(9):919-30. doi: 10.1016/0014-2964(78)90018-x.
5
Radiotherapy plus 5-FU compared to radiotherapy alone for inoperable and unresectable bronchogenic carcinoma.
Cancer. 1972 Feb;29(2):375-80. doi: 10.1002/1097-0142(197202)29:2<375::aid-cncr2820290218>3.0.co;2-h.
6
[Multimodal treatment in "clinical" non-small cell N2 bronchogenic carcinoma. What is the question?].["临床”非小细胞N2期支气管源性癌的多模式治疗。问题是什么?]
Arch Bronconeumol. 1995 Jan;31(1):43-4.
7
Combined modality therapy for stage IIIMO non-oat cell bronchogenic carcinoma.
Cancer Treat Rep. 1978 Mar;62(3):327-32.
8
Misonidazole and radiotherapy in lung cancer: a randomized double-blind trial.米索硝唑与肺癌放疗:一项随机双盲试验
Int J Radiat Oncol Biol Phys. 1982 Oct;8(10):1719-20. doi: 10.1016/0360-3016(82)90292-9.
9
Preliminary report on the treatment of nonresectable cancer of the lung.不可切除性肺癌治疗的初步报告
Cancer Chemother Rep. 1974 May-Jun;58(3):359-64.
10
[Bronchial anaplastic small-cell carcinoma. A balance sheet and therapeutic update].
Rev Esp Oncol. 1982;29(1):129-37.

引用本文的文献

1
Interim analyses and stopping rules in cancer clinical trials.癌症临床试验中的期中分析与终止规则。
Br J Cancer. 1993 Dec;68(6):1179-85. doi: 10.1038/bjc.1993.500.
2
Reduced survival with radiotherapy and razoxane compared with radiotherapy alone for inoperable lung cancer in a randomised double-blind trial.在一项随机双盲试验中,与单纯放疗相比,放疗联合丙亚胺用于无法手术的肺癌患者时生存率降低。
Br J Cancer. 1985 May;51(5):731-2. doi: 10.1038/bjc.1985.109.